carbamates has been researched along with Hyperlipoproteinemia Type II in 1 studies
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grigor'ian, VA | 1 |
| Klantsa, NA | 1 |
| Prishliak, VD | 1 |
| Klantsa, PN | 1 |
1 other study available for carbamates and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
[Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
Topics: Adult; Aged; Carbamates; Cholesterol; Chronic Disease; Coronary Disease; Female; Humans; Hyperlipopr | 1981 |